Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
for research and employees from all over the world. We are looking for a Staff Scientist – Mass Spectrometry Core Facility (m/f/d) (Ref 12/2025) to join the Core Facility ‘Mass Spectrometry’ led by Prof. Dr. Fan
-
January 2026 to (see button e-mail application below). https://jobs.zalf.de/jobposting/af3d771faf0a6dcc04a638f8f0d8f039bd501f6f0 If you have any questions, please do not hesitate to contact us: Dr. Ehsan
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our location in
-
, putting “WM 01-2026” in the subject line. Applications can only be accepted as a single PDF file. If you would like further information on the remit of the role, please email Prof. Dr. Isabella Löhr
-
16 February 2026, to the Director of the GWZO, Prof. Dr. Maren Röger (Reichsstr. 4–6, 04109 Leipzig). Applications may be submitted via our career portal (https://gwzo.jobs.personio.de/ ) or by email
-
Gesellschaft für Naturforschung Senckenberganlage 25 60325 Frankfurt a.M. E-Mail: recruiting(at)senckenberg.de If you have any specific questions about the position, please contact Prof. Dr. Andreas Mulch
-
upload your CV and motivation letter, by February 15th , 2026 via the online application system: https://www.leibniz-inm.de/en/job-offers-2/ For further information on this position, please contact INM
-
The Leibniz Graduate School on Aging (LGSA) is a joint program of the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) and the Friedrich Schiller University (FSU) in Jena. The School calls
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our location in
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu ) – is a biomedical research center focusing on translational immunology in the fields of cancer